Context: Metformin is the first-line drug for treating diabetes but has a high failure rate. Objective: To identify demographic and clinical factors available in the electronic health record (EHR) that predict metformin failure. Methods: A cohort of patients with at least 1 abnormal diabetes screening test that initiated metformin was identified at 3 sites (Arizona, Mississippi, and Minnesota). We identified 22 047 metformin initiators (48% female, mean age of 57 ± 14 years) including 2141 African Americans, 440 Asians, 962 Other/Multiracial, 1539 Hispanics, and 16 764 non-Hispanic White people. We defined metformin failure as either the lack of a target glycated hemoglobin (HbA1c) (<7%) within 18 months of index or the start of dual therapy. We used tree-based extreme gradient boosting (XGBoost) models to assess overall risk prediction performance and relative contribution of individual factors when using EHR data for risk of metformin failure. Results: In this large diverse population, we observed a high rate of metformin failure (43%). The XGBoost model that included baseline HbA1c, age, sex, and race/ethnicity corresponded to high discrimination performance (C-index of 0.731; 95% CI 0.722, 0.740) for risk of metformin failure. Baseline HbA1c corresponded to the largest feature performance with higher levels associated with metformin failure. The addition of other clinical factors improved model performance (0.745; 95% CI 0.737, 0.754, P
CITATION STYLE
Bielinski, S. J., Yanes Cardozo, L. L., Takahashi, P. Y., Larson, N. B., Castillo, A., Podwika, A., … Summers, R. L. (2023). Predictors of Metformin Failure: Repurposing Electronic Health Record Data to Identify High-Risk Patients. Journal of Clinical Endocrinology and Metabolism, 108(7), 1740–1746. https://doi.org/10.1210/clinem/dgac759
Mendeley helps you to discover research relevant for your work.